In conclusion, although the number of analyzed bone marrows was limited, our data imply that TEG011_CD8α effectively cleared tumor cells in bone marrow, emphasizing the role of CD8α co-stimulation for better in vivo tumor control of TEG011 cells. Here, CD8A is linked to neoplasm.